A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry sponsored.

The Birmingham VA Health Care System showed off its robotic-assisted tools available to veterans for early lung cancer ...

His research group at the University of Pennsylvania is developing a potential immunotherapy for lung and other thoracic cancers, based on chimeric antigen receptor (CAR) T cells. Adoptive T cell ...

The 2017 Multidisciplinary Thoracic Cancers Symposium, co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and The Society of Thoracic ...

We used SAS version 9.4 (SAS Institute Inc, Cary, NC) for statistical analyses. We identified 151 and 166 thoracic cancer cases before and after implementation of the information technology platform, ...

Thoracic medical oncologist at Yale Medicine, Dr Anne Chiang asserted: "We used to think all lung cancers were the same, but now we understand that there are different kinds." It is common for non ...

Investigators are developing this BH3 profiling technique for use in solid thoracic cancers with the goal of providing patient-specific, precision treatments by specific targeting of anti-apoptotic ...

which investigate mechanisms of carcinogenesis of thoracic cancers, explore cancer-immune system microenvironments, and examine ischemia-reperfusion injury in lung transplantation. We treat all ...

Lung cancer: A formidable foe As a thoracic oncologist at Massachusetts ... on the case The researchers set out to study lung cancers caused by an alteration in the ALK gene that leads to the ...

Method Professor of Surgery and director of the Canning Thoracic Institute ... to use this approach to benefit patients with advanced cancers that have not responded to other treatments." ...